期刊名称：EJSO
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
The EJSO is the Official Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. The EJSO aims to educate and inform about the many subspecialty disciplines of cancer surgery. The EJSO publishes original scientific articles, reviews, clinical trials, news and views, and other relevant material. The Journal seeks to capture the interest and attention of its worldwide print and electronic readership through excellence, clarity, simplicity and concise presentation of the written word and diagram.
The Editors welcome submissions from prospective authors in respect of Editorials on any subject of relevance to cancer surgical practice; Original Articles; specialist and general Review Articles; Educational Articles; Technical or "How I do it" Articles; News Items; Conference Reports; and Letters on any matters of general interest or on specialist topics. Research areas include: epidemiology and preventative aspects of oncology; diagnosis, including imaging; all aspects of therapy, including radiotherapy and chemotherapy; application of new equipment to surgical and clinical oncology; methods of assessing results of treatment; computing in relation to oncology. The Editors are also pleased to accept short book and web site reviews, clinical curios, personal commentaries and other original material of up to three hundred words. Concise, well-written, contextual and informative obituaries on individuals who have made a significant contribution to the science or practice of cancer surgery will also be considered for publication.
Instructions to Authors
Editorial policy is to develop the EJSO as the premier journal of communication in the sub-specialities of cancer surgery and the relevant life sciences. Please refer to http://www.ejso.com for a full description of the EJSO editorial policies and strategies. We welcome submission of manuscripts in the fields of epidemiology and preventive aspects of oncology; diagnosis, including imaging; all aspects of therapy, including radiotherapy and chemotherapy; application of new equipment to surgical and clinical oncology; methods of assessing results of treatment; computing in relation to oncology; in the following categories:
Editorials. These may be proffered on any subject of relevance to cancer surgical practice. It should offer informed comment on an issue of topical interest. An Editorial should generally be less that 1500 words and contain no more than 10 references.
Original Articles. These will be considered on all aspects of cancer surgery and related subjects, including clinical trials, case and clinico-pathological series, audit or experimentation.
Review Articles. These will be considered on all aspects of cancer surgery. The Editors encourage the submission of reviews that offer new insights or demonstrate specific expertise on the part of the authors.
We are also pleased to encourage submission of manuscripts in the following categories:
For Debate Articles. The Editors encourage the submission of well-written and well-argued articles For Debate on controversial issues of technique, practice or clinical science. Contributors are encouraged to identify authors who may be able to offer a contrary case to stimulate interest and debate.
Educational Articles. The Journal is particularly keen to promote postgraduate training and education. Discursive, informative and didactic articles will be considered by the Editors on a wide range of subjects. Authors should bear in mind the target audience and general professional readership.
Technical and "How I do it" Articles. The Editors invite descriptions of technique, with supporting evidence of efficacy and safety, for innovative procedures, operations and management strategies across the spectrum of cancer surgical practice.
News and Views Items. The Editors wish to develop the use of the EJSO for the early dissemination of news on clinical and scientific advances. They welcome submission of any contemporary items which would be of early interest to an international readership or which would help advance the understanding of professional practice between disciplines and countries or cultures.
Conference Reports. The Editors will be pleased to consider conference reports on major meetings. Reports should be informative and highlight important advances and insights. They should not exceed 1500 words.
Correspondence. The Editors are pleased to consider letters on any matter of contemporary interest, including those arising from previously published items in the EJSO.
Book and Web Site Reviews. The Editors are pleased to consider short commentaries and reviews of books, web sites or other digital media of potential interest to our readership. Items should be no more than 300 words in length.
Short Reports and Comments. The Editors welcome short items of up to 300 words on any topic or personal experience that may be of interest to our general readership.
Ethics
For clinical trials, details of ethical committee approval and the type of informed consent should be stated. Patients' and volunteers' names, initials and hospital numbers should not be used.
The Journal supports the principles of the Committee on Publication Ethics (COPE), which oblige the highest standards of practice on all participants in scientific research and publishing. Full details are available on the COPE website (http://www.publicationethics.org.uk). With limited resources, it is not possible for the Editors to identify or to be aware of all transgressions to the code of practice. Readers who identify or suspect publication fraud are asked to contact the Editors of the EJSO.
Previous Publication
No substantial part of the manuscript may have been or may be published elsewhere. This restriction does not apply to abstracts or press reports published in connection with scientific meetings. For advice on previous or simultaneous publication, contact the Editorial Office.
Submitting the Manuscript
Authors should submit four copies of the manuscript with four sets of figures (all copies of photomicrographs and gels should be of good quality) together with an electronic copy (full details of electronic submission can be obtained from http://www.authors.elsevier.com). Figures should not be imported into the text file. Full details for the electronic submission of artwork can be obtained from http://www.authors.elsevier.com. Submit all material to: Administrative Editor, EJSO Editorial Office, Health Sciences, Elsevier Science Ltd, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, UK (Tel: +44 (0) 1865 843753; fax: +44 (0) 1865 843992; e-mail: ejso@elsevier.com).
In a covering letter, please identify the person responsible for editorial correspondence (address, telephone and fax numbers, and e-mail address). The covering letter must be signed by the corresponding author on behalf of all the authors. Also include details of any previous or concurrent submission. It is also useful to state relevance, topicality, and whether any text, figures, or tables can be omitted. Receipt of all contributions is acknowledged immediately, with a reference number for enquiries.
EJSO is not responsible for the loss of manuscripts. Authors should keep a copy of the manuscript. EJSO does not return rejected manuscripts. One copy and all glossy artwork are stored for a month after the rejection date before disposal.
Authors should submit an electronic copy of their paper with the final version of the manuscript. The electronic copy should match the hard copy exactly.
Presentation and Preparation of Manuscripts
Format: Write in English with double line spacing on one side of single A4 sheets with high-quality print. EJSO will consider manuscripts prepared according to the Vancouver guidelines (Uniform requirements for manuscripts submitted to biomedical numbers. N Engl J Med 1991;324:424-428). Authors are advised to read these guidelines, especially when deciding on who qualifies as an author. Authors may also find useful: Guidelines for writing papers. Br Med J 1991;302:40-42. Manuscripts may be altered to meet EJSO style.
Manuscripts containing research data generally follow the order: Introduction, Patients (or Materials) and Methods, Results, and Discussion. Start each section at the top of a new page, and number all the pages.
Title page: The title page should include a concise but informative title; the authors' names; the department/institution and an address for each author, with a symbol to link authors and their addresses; the name, address, fax and telephone numbers, and e-mail address of the author to whom correspondence should be addressed; details of sources of support in the form of grants, equipment, and drugs.
Abstract: The second page should start with a structured abstract of up to 250 words, setting out succinctly the aims, methods, results and conclusions. An appropriate abstract should also be prepared for "For Debate" and Education section items.
Keywords: Please include up to 5 keywords from the Medical Subject Headings from Index Medicus
Text: This should start on the third page and should be divided into the following sections: Introduction, Patients (or Materials) and Methods, Results, and Discussion.
References: References should be listed on a new page. They should be numbered consecutively in parentheses in the text. 'Unpublished data' and 'Personal communications' are not allowed. As an alternative, say in the text, for example, '(data not shown)' or '(Dr F.G. Tomlin, Karolinska Institute)'. Accepted but unpublished papers (but not submitted manuscripts) can be referenced as 'in press'. Long reference lists impose a penalty on the available space and on the readability of the EJSO. References should be cited sparingly and selectively, and reference lists should generally be restricted to 30 references, other than in specialist review articles. The format of references should be that of the Vancouver guidelines. Include:
-The names of all the authors when six or fewer, followed by their initials. Otherwise list only the first three and add et al.
-The title of the article or chapter
-The journal name abbreviated as in Index Medicus, the year and volume, and the first and last pages
-For a book, the names of any editors (as for authors), the city and name of the publisher, and the year and pages.
Examples for an article in a journal (1), an edited book (2) or a book (3) would be:
1. Jiang FN, Liu DJ, Neyndorff H, Chester M, Jiang S-Y, Luy JG. Photodynamic killing of human squamous cell carcinoma cells using a monoclonal antibody-photosensitizer conjugate. J Natl Cancer Inst 1991;83:1218-1225.
2. Gullick WJ, Venter DJ. The c-erbB2 and its expression in human tumours. In Waxman J, Sikora K, (eds). The Molecular Biology of Cancer. Oxford: Blackwell Scientific Publications, 1989, 38-53.
3. Lumley JSP, Green CJ, Lear P. Angell-James JE, Essentials of Experimental Surgery. London: Butterworths, 1990.
Figures: Figures should be cited consecutively in the text. All figures should be original glossy photographs or professional drawings (high quality computer-generated artwork is acceptable). Please do not frame the figures. Mark the back of each figure with its number and the first author's name, and indicate the top of the figure. Figures are generally reduced to 84 mm wide or less when published. Type the legends in order on a separate page; limit the legend to 40 words or less. Full details for the electronic submission of artwork can be obtained from http://www.authors.elsevier.com.
Colour illustrations can be published at no charge to the author.
Tables: Tables should be cited consecutively in the text. Type tables on separate pages with a title. Avoid white spaces in the table by using footnotes, and ensure all symbols or abbreviation are explained. Take care to distinguish between 'zero' and 'not done' as an entry in the table. Tables should be used to present numerical or text data in a clear and selective way, so as economically to illustrate the message of the paper. Authors should avoid the compression of large quantities of information of marginal value to the general reader into dense tables, and the Editors will reserve the right to request modifications, deletions or omissions on a case-by-case basis. To improve readability, the EJSO will not publish large tables in landscape format other than in exceptional circumstances. All tables should be designed with consideration to normal orientation on the printed page. Columns of data, which do not add to the general utility or clarity, such as percentages alongside integer data, should be omitted.
Abbreviations and units. Generally, avoid abbreviations in the Title and abbreviating single words. Otherwise explain all abbreviations at first mention in the Abstract and text, except for: DNA, RNA, AIDS, and HIV. Standard SI abbreviations for units do not need to be spelt out.
Drug names. Use generic names for drugs. Commercial names may be included in parentheses at first mention in the text. Complicated drug names or regimens may be abbreviated, with the abbreviation in parentheses after first mention.
Copyright
All authors must sign the 'Transfer of Copyright' agreement before the article can be published. This transfer agreement enables Elsevier to protect the copyright material for the authors, but does not relinquish the author's proprietary rights. The copyright transfer covers the exclusive rights to reproduce and distribute the article, including reprints, photographic reproductions, microfilm or the right to adapt the article for use in conjunction with computer systems and programmes, including reproduction or publication in machine-readable form and incorporation in retrieval systems.
If excerpts (for example figures) from copyrighted works are included the author is responsible for obtaining written permission from the copyright holder prior to submitting the final version of the paper. Full credit must be given to such sources.
Proofs
Proofs in PDF format will be sent to the corresponding author via e-mail and should be returned within 48 hours of receipt. It is therefore essential to provide the full e-mail addresses of the corresponding author. Keep a copy of corrected proofs. Corrections should be restricted to typesetting errors as any substantial changes other than these may be charged to the author. The responsibility for detecting errors is with the author. Twenty-five offprints will be supplied free of charge. Further offprints and copies of the issue can be ordered at a specially reduced rate using the order form sent to the corresponding author by the Publisher.
Author enquiries
Visit the Author Gateway from Elsevier Science http://authors.elsevier.com for the facility to track accepted articles and set up e-mail alerts to inform you when an article's status changes. The Author Gateway also provides detailed artwork guidelines, copyright information, and answers to frequently asked questions.
Contact details for questions arising after acceptance of an article, especially those relating to proofs, are provided after registration of the article for publication.
Editorial Board
| Editor-in-Chief |
David Rew
EJSO Editorial Office
Health Sciences, Elsevier Science Ltd
The Boulevard, Langford Lane
Kidlington
Oxford, OX5 1GB
UK
Tel: +44 (0)1865 843753
Fax: +44 (0)1865 843992
Email: ejso@elsevier.com
|
| |
| Editor Emeritus |
I Taylor
UK
|
| |
| Associate Editors |
J Geraghty
UK
|
L Holmberg
Sweden
|
T Lehnert
Germany
|
J Thompson
Australia
|
CJH van de Velde
The Netherlands
|
| |
| Chairman of the Editorial Board |
N O'Higgins
Ireland
|
| |
| Ex Officio - BASO |
S Nicholson
UK
|
Z Rayter
UK
|
| |
| Ex Officio - ESSO |
H Beger
Germany
|
T Lerut
Belgium
|
| |
| Editorial Advisory Board - Breast Oncology |
R Blamey
UK
|
L Cataliotti
Italy
|
O Eremin
UK
|
F Given
Ireland
|
J Jaskiewicz
Poland
|
F Rochard
France
|
J Th Rutgers
The Netherlands
|
M Snoj
Slovenia
|
| |
| Editorial Advisory Board - GI Oncology |
TG Allen-Mersh
UK
|
UT Laffer
Switzerland
|
L Pahlman
Sweden
|
PJ Roberts
Finland
|
AJ Shorthouse
UK
|
M Smola
Austria
|
T Wiggers
The Netherlands
|
| |
| Editorial Advisory Board - HPB Oncology |
J Jeekel
The Netherlands
|
GJ Poston
UK
|
| |
| Editorial Advsiory Board - Endocrine Oncology |
M Blichert-Toft
Denmark
|
N O'Higgins
Ireland
|
HD Roeher
Germany
|
M Wheeler
UK
|
| |
| Editorial Advisory Board - Head and Neck Oncology |
AJM Balm
The Netherlands
|
J Prein
Switzerland
|
| |
| Editorial Advisory Board - Sarcoma |
HT Hoekstra
The Netherlands
|
JM Klausner
Israel
|
JM Thomas
UK
|
| |
| Editorial Advisory Board - Melanomas-Skin |
N Cascinelli
Italy
|
BBR Kroon
The Netherlands
|
F Lejeune
Switzerland
|
S Schneebaum
Israel
|
| |
| Editorial Advisory Board - Urological Oncology |
FC Hamdy
UK
|
D Newling
The Netherlands
|
| |
| Ed. Advisory Board - Med. Oncology & Radiotherapy |
H Bartelink
The Netherlands
|
A Goldhirsch
Switzerland
|
JA Ledermann
UK
|
M Roselli del Turco
Italy
|
| |
| Editorial Advisory Board - Paediatric Oncology |
DA Lloyd
UK
|
J Plaschkes
Switzerland
|
A Vos
The Netherlands
|
| |
| Editorial Advisory Board - Reconstructive Surgery |
AD McGregor
UK
|
| |
| Editorial Advisory Board - Regional Cancer Therapy |
Y Arai
Japan
|
G Fiorentini
Italy
|
P Sugarbaker
USA
|
| |
| Editorial Advisory Board - Thoracic Oncology |
IS Besznyak
Hungary
|
P Goldstraw
UK
|
| |
| Editorial Advisory Board - Pathology |
D Poller
UK
|
| |
| 
